Implementation of an Efficacious Intervention for High Risk Women in Mexico

Overview

This project seeks to determine the personal and organizational conditions that are most conducive to the widespread adoption by community-based organizations (CBOs) of effective programs for reducing the spread of HIV and other sexually transmitted infections (STIs). Taking a brief, single-session counseling program (called "Mujer Segura") that has been proven effective in reducing HIV and STIs in female sex workers who work in Mexican cities along the U.S. border, this project will study the implementation of the program in CBOs in 12 additional cities throughout Mexico to determine how best to ensure that the program remains true to the original model and retains its effectiveness. Mexico has been chosen because HIV is a global problem that respects no international borders, and because HIV prevention programs that can be implemented in settings with limited resources are urgently needed in many parts of the world.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Health Services Research
    • Masking: None (Open Label)
  • Study Primary Completion Date: April 2015

Interventions

  • Behavioral: Mujer Segura
    • Brief (35-minute) counseling intervention using techniques from Motivational Interviewing and principles of social cognitive theory (SCT) and theory of reasoned action (TRA).
  • Behavioral: CENSIDA counseling program
    • Didactic HIV and STI counseling involving some personal risk assessment and presenting appropriate information on methods of transmission and for avoiding or reducing the risk of infection. Based on a counseling manual disseminated by CENSIDA, Mexico’s federal HIV-AIDS prevention agency.

Arms, Groups and Cohorts

  • Experimental: Theory-based counseling (Mujer Segura)
    • Will consist of 40 FSWs at each of 12 clinics, randomized into this condition from a pool of 80 eligible participants.
  • Active Comparator: CENSIDA counseling program (didactic)
    • Will consist of 40 FSWs at each of 12 clinics, randomized into this condition from a pool of 80 eligible participants.

Clinical Trial Outcome Measures

Primary Measures

  • Reduction in HIV and STI incidence relative to control group
    • Time Frame: 6 months
    • Female sex worker (FSW) participants will be tested at baseline and 6-month follow-up for HIV, syphilis, gonorrhea, and Chlamydia. Incidence rates for all infections at 6-month follow-up will be compared between the theory-based Mujer Segura group (N=40 per clinic) and the standard counseling group (N=40 per clinic).
  • Reduction in number of unprotected sex acts relative to control group
    • Time Frame: 6 months
    • Female sex worker (FSW) participants will be assessed at baseline and 6-month follow-up using self-report measures of frequency of protected and unprotected sex acts with male clients. Changes in frequency at 6-month follow-up will be compared between the theory-based Mujer Segura group (N=40 per clinic) and the standard counseling group (N=40 per clinic).

Secondary Measures

  • Fidelity to Mujer Segura intervention model
    • Time Frame: 6 months
    • Counselors at each CBO will be assessed for their fidelity to the intervention protocol and assigned a numerical score. This number will be used to determine possible correlations between levels of fidelity and the efficacy of the Mujer Segura intervention at each clinic.

Participating in This Clinical Trial

Inclusion Criteria

  • At least 18 years of age – Self-identify as female sex worker – Exchanged sex for money, drugs, shelter, or other benefit in last 2 months – Had unprotected anal or vaginal sex with male client at least once in last 2 months – Agree to be tested for HIV & STIs at baseline and 6-month follow-u0 Exclusion Criteria:

  • Previous positive HIV test result

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University of California, San Diego
  • Collaborator
    • National Institute of Mental Health (NIMH)
  • Provider of Information About this Clinical Study
    • Principal Investigator: Thomas L. Patterson, Principal Investigator – University of California, San Diego
  • Overall Official(s)
    • Thomas L Patterson, Ph.D., Principal Investigator, University of California, San Diego

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.